NEW Special Report on UK
Despite a myriad of uncertainties around its decision to leave the European Union, the UK still stands as one of…
Patrick is an editor at PharmaBoardroom, writing and editing stories on all things healthcare and the life sciences. The holder of a Master's Degree in International Relations, Patrick has contributed to over 40 country reports and is a fluent Mandarin speaker.
Despite a myriad of uncertainties around its decision to leave the European Union, the UK still stands as one of…
Founded in 1998, GW Pharmaceuticals is a true pioneer in cannabinoid medicines and the only pharmaceutical company…
A confluence of factors – urbanisation, industrialisation, poor eating habits and a sedentary lifestyle…
As cannabis in Canada cruises towards legalization, Pharma giants race for patented products. Big Pharma is…
With Spain now on the road to economic recovery following the ravages of the global financial crisis, multinational…
Brexit, Brexit, Brexit. It’s all anyone can talk about and yet nobody can tell you with certainty what to expect.…
One notable quirk of the British life sciences ecosystem is the importance of its not-for-profit sector. Indeed, in…
The new AI tech from Google’s DeepMind can diagnose over 50 retinal diseases with more accuracy than your…
Portugal has forged a name for itself in terms of early adoption of new technology and ideas; making the country a…
Spanish biotech ALGENEX is using insect pupae to develop high-purity vaccines more quickly and at a lower cost than…
With the US FDA approval of a 3D bioprinted drug in 2016, the floodgates have been opened for a new wave of…
UMANA T1 – a patient monitoring ecosystem that uses tattoo sensor technology to measure and record heart rate and…